Khan I H, Catto G R, Edward N, MacLeod A M
Department of Medicine and Therapeutics, University of Aberdeen, UK.
QJM. 1994 Sep;87(9):559-64.
Factors influencing referral of all 304 patients who developed persistent renal failure during one year were studied in the stable Grampian population. The annual incidence of chronic renal failure (CRF) (creatinine > or = 300 mumol/l) was 450/million of the population and of persistent advanced CRF (creatinine > or = 500 mumol/l), 132/million. After excluding those aged > 80 years and those with advanced malignancy, the corresponding incidence figures were 240/million/year and 81/million/year. Only 109 patients (35.8%) were referred to a nephrologist. Patients were divided according to age and coexisting disease into low, medium and high risk groups; 69% of CRF patients in the low, 58% in the medium, and 21% in the high risk group were referred (100%, 88% and 37%, respectively, of the patients with advanced CRF). Two-year patient survival in the low, medium and high risk groups was 100%, 63% and 27%, respectively, in referred patients, and 100%, 48% and 14%, respectively, in non-referred patients. This method of risk stratification identifies patients (particularly those with advanced CRF) likely to have a poor outcome irrespective of referral to a nephrologist. Earlier referral for interventions to delay the progress of the patients' renal and comorbid illnesses has considerable implications for future planning and funding of renal services.
在格兰扁地区稳定的人群中,对在一年期间出现持续性肾衰竭的304例患者的转诊影响因素进行了研究。慢性肾衰竭(CRF)(肌酐≥300μmol/L)的年发病率为每百万人口450例,持续性晚期CRF(肌酐≥500μmol/L)的年发病率为每百万人口132例。排除80岁以上患者和晚期恶性肿瘤患者后,相应的发病率分别为每年每百万人口240例和81例。只有109例患者(35.8%)被转诊至肾病科医生处。根据年龄和并存疾病将患者分为低、中、高风险组;低风险组中69%的CRF患者、中风险组中58%的患者以及高风险组中21%的患者被转诊(晚期CRF患者分别为100%、88%和37%)。在被转诊患者中,低、中、高风险组的患者两年生存率分别为100%、63%和27%,在未被转诊患者中分别为100%、48%和14%。这种风险分层方法可识别出无论是否转诊至肾病科医生处都可能预后不良的患者(尤其是晚期CRF患者)。尽早转诊以采取干预措施延缓患者肾脏疾病和合并症的进展,对未来肾脏服务的规划和资金投入具有重大意义。